Gilead gives glimpse into feverish drug market – ZAWYA

Gilead gives glimpse into feverish drug market – ZAWYA

Gilead gives glimpse into feverish drug market | ZAWYA MENA Edition HomeBusinessArticleGilead gives glimpse into feverish drug market The $2,300 price of a course of remdesivir may sound high - and is compared with the basic cost of manufacturing the stuff - but is actually fairly restrained    A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. (The author is a Reuters Breakingviews columnist. The opinions expressed are his own.)NEW YORK  - Medicine may be a science but drug pricing is definitely an art. That's especially true of Gilead Sciences' GILD.O treatment for Covid-19, given the lack of alternative treatments for a pandemic. The $2,300 price of a course of remdesivir may sound high - and is compared with the basic cost of manufacturing the stuff - but is actually fairly restrained.Start at the bottom. The marginal cost of producing remdesivir is probably less than $600, according to the Institute for Clinical and Economic Review, an independent non-profit. But companies must spend heavily to research and develop drugs. Factor in Gilead's development expenses for 2020 and the cost rises to $1,600.NEW YORK  - Medicine may be a science but drug pricing is definitely an